Drug recall · March 13, 2024
Methylprednisolone acetate Injectable Suspension recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
- Lots / codes
Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
- Quantity
- 10,080 vials
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- OH, TN, LA, MS
- Initiated
- February 20, 2024 · Voluntary: Firm initiated
- Classified
- March 4, 2024
- Reported
- March 13, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylprednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.